Overview
Antonio Tufaro practices practicing medicine in Bari, Italy.
His clinical expertise encompasses Extramammary Paget Disease, Ovarian Cancer, and Anaplastic Thyroid Cancer.
He is actively involved in clinical research, co-authoring 19 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Antonio Tufaro
Is Antonio Tufaro a top-rated expert for Extramammary Paget Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Antonio Tufaro is classified as an Experienced expert for Extramammary Paget Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Antonio Tufaro participate in research or clinical trials?
Yes. Antonio Tufaro has published 19 articles and abstracts on conditions like Extramammary Paget Disease. You can view a list of Antonio Tufaro's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anaplastic Thyroid CancerMr. Tufaro isExperienced. Learn about Anaplastic Thyroid Cancer.
- Extramammary Paget DiseaseMr. Tufaro isExperienced. Learn about Extramammary Paget Disease.
- Ovarian CancerMr. Tufaro isExperienced. Learn about Ovarian Cancer.